INTRODUCTION: Chronic traumatic encephalopathy (CTE) is a postmortem diagnosis. Consensus postmortem, but not antemortem, diagnostic criteria have been established. A key factor in these criteria is evidence of phosphorylated-tau (p-tau) around sulcal vessels in the cortex. However, this sign has been observed anecdotally in a diverse range of neurodegenerative diseases (NDD). We therefore hypothesise that this criterion may lack specificity. METHODS: To test this, we assessed patients with NDD, but no documented history of brain trauma, for sulcal p-tau. Tissue was retrieved from Dublin Brain Bank (known NDD n = 17; control with no diagnosed NDD n = 6; CTE n = 1), and slides were prepared from three sites with a predilection for trauma: superior frontal gyrus, temporal pole, and superior temporal gyrus. We stained the resulting anonymised slides with both hemotoxylin and eosin (H&E) and p-tau. Three neuropathologists, blinded to the clinical history and neuropathological diagnosis in each instance, evaluated each case for sulcal p-tau. We calculated the interrater agreement, using Fleiss's kappa, and the specificity of this neuropathological sign. RESULTS: Sulcal p-tau was highly specific to diagnosed CTE cases (specificity 0.98), with moderate interrater agreement (κ = 0.45). CONCLUSION: In conclusion, therefore, we observed sulcal p-tau to be a sign highly specific to CTE when compared with NDD cases in the absence of head trauma.
INTRODUCTION:Chronic traumatic encephalopathy (CTE) is a postmortem diagnosis. Consensus postmortem, but not antemortem, diagnostic criteria have been established. A key factor in these criteria is evidence of phosphorylated-tau (p-tau) around sulcal vessels in the cortex. However, this sign has been observed anecdotally in a diverse range of neurodegenerative diseases (NDD). We therefore hypothesise that this criterion may lack specificity. METHODS: To test this, we assessed patients with NDD, but no documented history of brain trauma, for sulcal p-tau. Tissue was retrieved from Dublin Brain Bank (known NDD n = 17; control with no diagnosed NDD n = 6; CTE n = 1), and slides were prepared from three sites with a predilection for trauma: superior frontal gyrus, temporal pole, and superior temporal gyrus. We stained the resulting anonymised slides with both hemotoxylin and eosin (H&E) and p-tau. Three neuropathologists, blinded to the clinical history and neuropathological diagnosis in each instance, evaluated each case for sulcal p-tau. We calculated the interrater agreement, using Fleiss's kappa, and the specificity of this neuropathological sign. RESULTS: Sulcal p-tau was highly specific to diagnosed CTE cases (specificity 0.98), with moderate interrater agreement (κ = 0.45). CONCLUSION: In conclusion, therefore, we observed sulcal p-tau to be a sign highly specific to CTE when compared with NDD cases in the absence of head trauma.
Authors: Lee E Goldstein; Andrew M Fisher; Chad A Tagge; Xiao-Lei Zhang; Libor Velisek; John A Sullivan; Chirag Upreti; Jonathan M Kracht; Maria Ericsson; Mark W Wojnarowicz; Cezar J Goletiani; Giorgi M Maglakelidze; Noel Casey; Juliet A Moncaster; Olga Minaeva; Robert D Moir; Christopher J Nowinski; Robert A Stern; Robert C Cantu; James Geiling; Jan K Blusztajn; Benjamin L Wolozin; Tsuneya Ikezu; Thor D Stein; Andrew E Budson; Neil W Kowall; David Chargin; Andre Sharon; Sudad Saman; Garth F Hall; William C Moss; Robin O Cleveland; Rudolph E Tanzi; Patric K Stanton; Ann C McKee Journal: Sci Transl Med Date: 2012-05-16 Impact factor: 17.956
Authors: Samuel M Goldman; Caroline M Tanner; David Oakes; Grace S Bhudhikanok; Anjali Gupta; J William Langston Journal: Ann Neurol Date: 2006-07 Impact factor: 10.422
Authors: Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu Journal: Brain Date: 2012-12-02 Impact factor: 13.501
Authors: Gary W Small; Vladimir Kepe; Prabha Siddarth; Linda M Ercoli; David A Merrill; Natacha Donoghue; Susan Y Bookheimer; Jacqueline Martinez; Bennet Omalu; Julian Bailes; Jorge R Barrio Journal: Am J Geriatr Psychiatry Date: 2013-01-22 Impact factor: 4.105
Authors: Ann C McKee; Robert C Cantu; Christopher J Nowinski; E Tessa Hedley-Whyte; Brandon E Gavett; Andrew E Budson; Veronica E Santini; Hyo-Soon Lee; Caroline A Kubilus; Robert A Stern Journal: J Neuropathol Exp Neurol Date: 2009-07 Impact factor: 3.685
Authors: J A Mortimer; C M van Duijn; V Chandra; L Fratiglioni; A B Graves; A Heyman; A F Jorm; E Kokmen; K Kondo; W A Rocca Journal: Int J Epidemiol Date: 1991 Impact factor: 7.196
Authors: Joseph C Maroon; Robert Winkelman; Jeffrey Bost; Austin Amos; Christina Mathyssek; Vincent Miele Journal: PLoS One Date: 2015-02-11 Impact factor: 3.240
Authors: Robert A Stern; Daniel H Daneshvar; Christine M Baugh; Daniel R Seichepine; Philip H Montenigro; David O Riley; Nathan G Fritts; Julie M Stamm; Clifford A Robbins; Lisa McHale; Irene Simkin; Thor D Stein; Victor E Alvarez; Lee E Goldstein; Andrew E Budson; Neil W Kowall; Christopher J Nowinski; Robert C Cantu; Ann C McKee Journal: Neurology Date: 2013-08-21 Impact factor: 9.910